The study did not control for covariates that were unavailable, such as HbA1c and duration of diabetes.CONCLUSIONS: Patients initiating exenatide vs liraglutide for T2DM had similar medication adherence and total healthcare costs; however, exenatide patients had significantly lower total pharmacy costs.